The US Food and Drug Administration (FDA) has published details of a warning letter to Herbert Fisk Johnson on June 11, 2019 regarding an inspection at SC Johnson Professional, Inc. (formerly Deb USA, Inc.) in Stanley, NC, from October 22 to 30, 2018. The warning letter summarizes what FDA calls significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals (see 21 CFR, parts 210 and 211) and requirements for registration and listing of drug product...